Signal TrAnsduction Pathway Activity Analysis in OVarian cancER

NCT03458221 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

148

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Ovarian Cancer
Signal Transduction Pathway Deregulation
Therapy-Associated Cancer

Interventions

DRUG: Letrozole Oral Product
DRUG: Bicalutamide Oral Product
DRUG: Everolimus Oral Product
DRUG: Itraconazole Oral Product

Sponsor

Gynaecologisch Oncologisch Centrum Zuid

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]